Tate & Lyle plc (LON:TATE – Get Free Report)’s stock price crossed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of GBX 436.36 and traded as high as GBX 556. Tate & Lyle shares last traded at GBX 554.50, with a volume of 1,395,635 shares trading hands.
Analyst Upgrades and Downgrades
Several equities analysts recently weighed in on TATE shares. UBS Group restated a “neutral” rating and issued a GBX 375 price target on shares of Tate & Lyle in a research note on Monday, May 18th. Berenberg Bank increased their price target on Tate & Lyle from GBX 464 to GBX 554 and gave the stock a “hold” rating in a research report on Wednesday, May 27th. Finally, Deutsche Bank Aktiengesellschaft reissued a “hold” rating and issued a GBX 595 price objective on shares of Tate & Lyle in a report on Friday, June 26th. One equities research analyst has rated the stock with a Buy rating and three have given a Hold rating to the company. According to data from MarketBeat, the company has a consensus rating of “Hold” and an average target price of GBX 516.
Read Our Latest Stock Report on TATE
Tate & Lyle Trading Up 0.3%
Tate & Lyle (LON:TATE – Get Free Report) last released its earnings results on Thursday, May 21st. The company reported GBX 22 EPS for the quarter. Tate & Lyle had a net margin of 4.84% and a return on equity of 6.17%. The business had revenue of GBX 200.60 billion during the quarter. Equities analysts expect that Tate & Lyle plc will post 51.3392857 EPS for the current fiscal year.
About Tate & Lyle
Tate & Lyle PLC, together with its subsidiaries, provides ingredients and solutions to the food, beverage, and other industries in the United States, the United Kingdom, other European countries, and internationally. It operates through three segments: Food & Beverage Solutions, Sucralose, and Primary Products. The company offers dairy products, soups, sauces, and dressings; bakery products and snacks; texturants; nutritive sweeteners, such as high fructose corn syrup and dextrose; fibres; and stabilizers and functional systems.
Featured Stories
- Five stocks we like better than Tate & Lyle
- Microsoft Just Flipped the AI Spending Narrative Overnight
- Qualcomm’s Turnaround Is Working, So Why Is Wall Street Selling?
- Meta’s Earnings Show Why Wall Street Is Losing Patience With AI Spending
- Can Starbucks Keep This Turnaround Going? The Latest Results Say Yes
Receive News & Ratings for Tate & Lyle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tate & Lyle and related companies with MarketBeat.com's FREE daily email newsletter.
